Ibsa Pharma recalls
FDA enforcement reports naming IBSA PHARMA INC as the recalling firm.
- Recall reports
- 15
- Class I (serious)
- 0
- Most recent report
- Mar 1, 2023
- Mar 1, 2023TIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mLDrug · IBSA PHARMA INCSubpotent DrugClass II
- Mar 1, 2023TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mLDrug · IBSA PHARMA INCSubpotent DrugClass II
- Mar 1, 2023TIROSINT - SOL (levothyroxine sodium) Oral Solution, 125 microgram/mLDrug · IBSA PHARMA INCSubpotent DrugClass II
- Mar 1, 2023TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mLDrug · IBSA PHARMA INCSubpotent DrugClass II
- Mar 1, 2023TIROSINT - SOL (levothyroxine sodium) Oral Solution, 25 microgram/mLDrug · IBSA PHARMA INCSubpotent DrugClass II
- Mar 1, 2023TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37Drug · IBSA PHARMA INCSubpotent DrugClass II
- Mar 1, 2023TIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mLDrug · IBSA PHARMA INCSubpotent DrugClass II
- Mar 1, 2023TIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mLDrug · IBSA PHARMA INCSubpotent DrugClass II
- Mar 1, 2023TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62Drug · IBSA PHARMA INCSubpotent DrugClass II
- Mar 1, 2023TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mLDrug · IBSA PHARMA INCSubpotent DrugClass II
- TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL
- TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL
- TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL
- TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL
- TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL
Page 1 of 2